RE-EMERGENT TREMOR IN ESSENTIAL TREMOR; A PLUS SIGN FOR ET PLUS ?
Objective: This study aimed to investigate whether re-emergent tremor (RET) might also occur in essential tremor (ET) and if the cases with this additional sign…Neuroimaging in Glucocerebrosidase-associated parkinsonism: a systematic review
Objective: To critically review studies applying neuroimaging to Glucocerebrosidase (GBA)-associated parkinsonism. Background: Mutations in the GBA gene cause Gaucher disease (GD) and constitute the most…Psychiatric evaluation according to Brief Psychiatric Rating Scale-Expanded in patients with Parkinson’s disease
Objective: The aim of the study was to evaluate psychiatric manifestations of Parkinson’s disease (PD) and to establish statistical links with sociodemographic and clinical PD…Anti-IgLON5 mediated autoimmune encephalitis presenting with hemichorea
Objective: In the present case report, we aim to describe a patient suffering from a seldom autoimmune encephalitis presenting with isolated progressive hemichorea. Background: Anti-IgLON5…Goals for Improvement in Essential Tremor Patients Following Focused Ultrasound VIM Thalamotomy
Objective: To report the most common expectations prior to focused ultrasound (FUS) treatment in essential tremor (ET) patients using the Goal Attainment Scaling method (GAS).…Phase-amplitude coupling between beta power and high frequency oscillations as a sensitive marker of parkinsonian state.
Objective: The aim of this work was to study the potential clinical usefulness of the phase-amplitude coupling (PAC) between beta power and high frequency oscillations (HFO´s).…Ballet for Parkinson’s disease, a new concept: Remote delivery via the English National Ballet’s Dance for Parkinson’s programme
Objective: To explore the characteristics and subjective outcomes for People with Parkinson’s (PwP) attending online Dance for Parkinson’s sessions professionally delivered by the English National…Safety and tolerability of Nilotinib in patients with Huntington’s disease
Objective: To investigate the safety and tolerability of nilotinib, an FDA-approved drug for leukemia, in individuals with Huntington’s disease (HD). Background: Previous clinical studies in…Comorbid neuropathological features in multiple system atrophy
Objective: To elucidate the distribution of comorbid neuropathology in multiple system atrophy (MSA) and its clinical correlation. Background: Multiple protein accumulations are often present in…Administration of the mGlu2 positive allosteric modulator BINA as monotherapy improves parkinsonism in the MPTP-lesioned marmoset
Objective: To assess the effect of selective metabotropic glutamate type 2 (mGlu2) receptor activation on parkinsonism as monotherapy in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset compared to…
- « Previous Page
- 1
- …
- 29
- 30
- 31
- 32
- 33
- …
- 153
- Next Page »